The fourth generation of enhancements to Parexel’s Randomization and Trial Supply Management (RTSM) service aims to simplify patient randomization and clinical supply management to reduce delivery timelines.
Sample and assay technology provider Qiagen has launched a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS).
Specialty CRO DaVita Clinical Research has expanded its clinical trials capabilities in Germany, Poland and Portugal.
European private equity firm Cinven has agreed to acquire a significant majority stake in France’s Labco for €1.2bn ($1.3m).
Sovaldi maker Gilead Sciences has opened a new laboratory and is investing a further $100m (€91m) for API manufacturing at its site in Canada.
From new service offerings to manufacturing deals to more formal strategic partnerships, the world of contract research and manufacturing organizations has been busy as of late. Here’s a roundup of some of the deals and new offerings: